Search Results - "Vanhoutvin, Steven A L W"

Butyrate-induced transcriptional changes in human colonic mucosa by Vanhoutvin, Steven A L W, Troost, Freddy J, Hamer, Henrike M, Lindsey, Patrick J, Koek, Ger H, Jonkers, Daisy M A E, Kodde, Andrea, Venema, Koen, Brummer, Robert J M

“…Fermentation of dietary fiber in the colon results in the production of short chain fatty acids (mainly propionate, butyrate and acetate). Butyrate modulates a…”
Get full text

Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy by Haanstra, Jasmijn F, de Vos tot Nederveen Cappel, Wouter H, Gopie, Jessica P, Vecht, Juda, Vanhoutvin, Steven A. L W, Cats, Annemieke, van der Zaag-Loonen, Hester J, Langers, Alexandra M J, Bergmann, Jerry H W, van de Meeberg, Paul C, Dekker, Evelien, Kleibeuker, Jan H, Vasen, Hans F A, Nagengast, Fokko M, van Duijvendijk, Peter

“…BACKGROUND:Lynch syndrome is a disorder caused by mismatch repair gene mutations. Mutation carriers have a high risk of developing colorectal cancer. In…”
Get full text

Butyrate modulates oxidative stress in the colonic mucosa of healthy humans by Hamer, Henrike M, Jonkers, Daisy M.A.E, Bast, Aalt, Vanhoutvin, Steven A.L.W, Fischer, Marc A.J.G, Kodde, Andrea, Troost, Freddy J, Venema, Koen, Brummer, Robert-Jan M

“…Summary Background & Aims Butyrate, a short-chain fatty acid produced by colonic microbial fermentation of undigested carbohydrates, has been implicated in the…”
Get full text

Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission by Hamer, Henrike M, Jonkers, Daisy M.A.E, Vanhoutvin, Steven A.L.W, Troost, Freddy J, Rijkers, Ger, de Bruïne, Adriaan, Bast, Aalt, Venema, Koen, Brummer, Robert-Jan M

“…Summary Background & Aims Butyrate, produced by colonic fermentation of dietary fibers is often hypothesized to beneficially affect colonic health. This study…”
Get full text

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study by Meulendijks, Didier, Beerepoot, Laurens V., Boot, Henk, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Vanhoutvin, Steven A. L. W., Polee, Marco B., Beeker, Aart, Portielje, Johanna E. A., de Jong, Robert S., Goey, Swan H., Kuiper, Maria, Sikorska, Karolina, Beijnen, Jos H., Tesselaar, Margot E., Schellens, Jan H. M., Cats, Annemieke

“…Summary Objective To investigate the efficacy of bevacizumab and trastuzumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOCT) as first-line…”
Get full text

Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trial by van Heel, Nicole C.M., MD, PhD, Haringsma, Jelle, MD, Boot, Henk, MD, PhD, Cats, Annemieke, MD, PhD, Vanhoutvin, Steven A.L.W., MD, Kuipers, Ernst J., MD, PhD

“…Background Self-expanding metal stents (SEMSs) provide effective palliation in patients with malignant dysphagia. However, although life expectancy is…”
Get full text

Butyrate enemas do not affect human colonic MUC2 and TFF3 expression by Hamer, Henrike M, Jonkers, Daisy M.A.E, Renes, Ingrid B, Vanhoutvin, Steven A.L.W, Kodde, Andrea, Troost, Freddy J, Venema, Koen, Brummer, Robert-Jan M

“…INTRODUCTIONThe colonic mucus layer plays an important role in the protection of the intestinal epithelium and mainly consists of mucin glycoproteins…”
Get full text

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first‐line treatment of patients with advanced HER2‐negative gastric cancer: A multicenter phase 2 study by Meulendijks, Didier, de Groot, Jan Willem B., Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E.A., Goey, Swan H., de Jong, Robert S., Vanhoutvin, Steven A.L.W., Kuiper, Maria, Sikorska, Karolina, Pluim, Dick, Beijnen, Jos H., Schellens, Jan H.M., Grootscholten, Cecile, Tesselaar, Margot E.T., Cats, Annemieke

“…BACKGROUND The current study was a multicenter, single‐arm, phase 2 study performed to investigate the feasibility and efficacy of bevacizumab combined with…”
Get full text

Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy by Haanstra, Jasmijn F, Al-Toma, Abdul, Dekker, Evelien, Vanhoutvin, Steven A L W, Nagengast, Fokko M, Mathus-Vliegen, Elisabeth M, van Leerdam, Monique E, de Vos tot Nederveen Cappel, Wouter H, Sanduleanu, Silvia, Veenendaal, Roeland A, Cats, Annemieke, Vasen, Hans F A, Kleibeuker, Jan H, Koornstra, Jan J

“…The aim was to determine the prevalence of small-bowel neoplasia in asymptomatic patients with Lynch syndrome (LS) by video capsule endoscopy (VCE). After…”
Get more information

Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy by Haanstra, Jasmijn, Al-Toma, Abdul, Dekker, Evelien, Vanhoutvin, Steven, Nagengast, Fokko, Mathus-Vliegen, Elisabeth, van Leerdam, Monique, de Vos tot Nederveen Cappel, Wouter, Veenendaal, Roeland, Cats, Annemieke, Sanduleanu, Silvia, Vasen, Hans, Kleibeuker, Jan, Koornstra, Jan

“…Abstract Background and study aims Lynch syndrome (LS) patients have an increased risk of small bowel cancer. The question is whether surveillance will lead to…”
Get full text